Shandong Weigao Group Medical Polymer Company Limited

SHSC:1066 Stock Report

Market Cap: HK$21.0b

Shandong Weigao Group Medical Polymer Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rinan Cong

Chief executive officer

CN¥4.0m

Total compensation

CEO salary percentage42.1%
CEO tenureno data
CEO ownership0.05%
Management average tenure2.5yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rinan Cong's remuneration changed compared to Shandong Weigao Group Medical Polymer's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥4mCN¥2m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥3b

Dec 31 2022CN¥5mCN¥950k

CN¥3b

Sep 30 2022n/an/a

CN¥3b

Jun 30 2022n/an/a

CN¥3b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥3mCN¥903k

CN¥2b

Compensation vs Market: Rinan's total compensation ($USD546.68K) is about average for companies of similar size in the Hong Kong market ($USD471.06K).

Compensation vs Earnings: Rinan's compensation has been consistent with company performance over the past year.

CEO

Rinan Cong (43 yo)

no data

Tenure

CN¥3,990,000

Compensation

Mr. Rinan Cong served as Chief Executive Officer at Shandong Weigao Group Medical Polymer Company Limited since March 30, 2021 until 2024 and served as Executive Director since May 24, 2021 until 2024 and...

Leadership Team

NamePositionTenureCompensationOwnership
Jing Long
Executive Chairman of the Board & Compliance Officer6yrsCN¥8.27m0.14%
HK$ 29.7m
Rinan Cong
Chief Executive Officerno dataCN¥3.99m0.048%
HK$ 10.1m
Junqiang Lu
Executive Director2.5yrsCN¥1.32mno data
Xue Feng Wu
Chief Financial Officer7.8yrsno datano data
Xia Yan
Non-Executive Directorless than a yearno datano data
Daoming Wang
Executive Directorless than a yearno data0.011%
HK$ 2.3m
Miu Ling Wong
Company Secretary18.6yrsno datano data

2.5yrs

Average Tenure

49yo

Average Age

Experienced Management: 1066's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jing Long
Executive Chairman of the Board & Compliance Officer6yrsCN¥8.27m0.14%
HK$ 29.7m
Junqiang Lu
Executive Director2.5yrsCN¥1.32mno data
Xia Yan
Non-Executive Directorless than a yearno datano data
Daoming Wang
Executive Directorless than a yearno data0.011%
HK$ 2.3m
Lin Chen
Non-Executive Director3.8yrsno datano data
Hong Meng
Independent Non-Executive Director2.3yrsCN¥150.00kno data
Guohui Li
Independent Non-Executive Director2.5yrsCN¥207.00kno data
Zhengpeng Tang
Vice Chairman3.8yrsno datano data
Meijun Gu
Chairman of the Supervisors4.4yrsno datano data
Zhuangqiu Zhang
Employee Representative Supervisor2.7yrsno datano data
Qiang Li
Independent Non-Executive Director2yrsCN¥150.00kno data
Heng Sun
Independent Non-Executive Directorless than a yearno datano data

2.5yrs

Average Tenure

49yo

Average Age

Experienced Board: 1066's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:45
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Weigao Group Medical Polymer Company Limited is covered by 35 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason MannBarclays
Derrick SunBNP Paribas Securities (Asia)
Feng Qiang SunBOCOM International Securities Limited